Tünbekici, S. Et Al. 2025. Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study. Cancers , vol.17, no.1 .

Tünbekici, S., Yuksel, H. c., Acar, C., Sahin, G., Orman, S., Majidova, N., ... COŞKUN, A.(2025). Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study. Cancers , vol.17, no.1.

Tünbekici, Salih Et Al. "Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study," Cancers , vol.17, no.1, 2025

Tünbekici, Salih Et Al. "Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study." Cancers , vol.17, no.1, 2025

Tünbekici, S. Et Al. (2025) . "Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study." Cancers , vol.17, no.1.

@article{article, author={Salih Tünbekici Et Al. }, title={Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study}, journal={Cancers}, year=2025}